IQWiG's methods for the cost-benefit assessment. Comparison with an international reference scenario

被引:0
|
作者
Schwalm, A. [1 ]
Danner, M. [1 ]
Seidl, A. [1 ]
Volz, F. [1 ]
Dintsios, C. M. [1 ]
Gerber, A. [1 ]
机构
[1] IQWiG, D-51105 Cologne, Germany
关键词
Institute for Quality and Efficiency in Health Care; Health economic evaluation/methods; Reference case; Quality-adjusted life year (QALY); GENERAL-POPULATION; HEALTH; PREFERENCES; EFFICIENCY; DECISIONS; DRUGS; EQ-5D;
D O I
10.1007/s00103-010-1067-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Standardization of international health economic guidelines has been repeatedly requested. In this context, an international reference case was proposed, which constitutes an agreed approach for the key elements of health economic evaluation including study perspective, comparators, source of effectiveness data, role of modeling, main (economic) outcome, source of utilities, characterizing uncertainty. It is, however, questionable whether such a reference scenario can reasonably be applied across all health care systems. Our analysis pursues the question to which degree the Institute for Quality and Efficiency in Health Care's (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, IQWiG)"General methods for evaluating the relation between cost and benefit" comply with the key elements of the reference case. In case of divergences, they will be described and discussed in light of the German social legislation and in consideration of current scientific evidence. In conclusion, the analysis revealed that IQWiG complied with the reference case in almost all aspects. Differences were found only with respect to the choice of main (economic) outcome and the source of utilities. These differences seem justified and well explained in the context of the German social legislation as well as in view of the weaknesses of the quality-adjusted life year (QALY) concept.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 50 条
  • [21] The assessment of cost-benefit relationships of medical procedures
    Koch K.
    Sawicki P.T.
    Medizinrecht, 2010, 28 (4) : 240 - 244
  • [22] A cost-benefit analysis of an international dual degree programme
    Asgary, Nader
    Robbert, Mary
    JOURNAL OF HIGHER EDUCATION POLICY AND MANAGEMENT, 2010, 32 (03) : 317 - 325
  • [23] Concepts and application of cost-benefit evaluation in an international overview
    Greiner, Wolfgang
    Witte, Julian
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2022, 174 : 111 - 118
  • [24] Preventive and corrective maintenance - cost comparison and cost-benefit analysis
    Stenstrom, Christer
    Norrbin, Per
    Parida, Aditya
    Kumar, Uday
    STRUCTURE AND INFRASTRUCTURE ENGINEERING, 2016, 12 (05) : 603 - 617
  • [25] COST-BENEFIT OF SCREENING FOR TYPE-1 DIABETES - A FUTURISTIC SCENARIO
    LEVYMARCHAL, C
    DIABETES & METABOLISM, 1993, 19 (5BIS): : 538 - 545
  • [26] Cost-benefit Analysis of Virtual Power Plant for Demand Response Scenario
    Tian, Shijun
    Zhang, Gao
    Hu, Yuan
    Ma, Li
    2022 9TH INTERNATIONAL FORUM ON ELECTRICAL ENGINEERING AND AUTOMATION, IFEEA, 2022, : 11 - 14
  • [27] A comparison of visual and molecular methods for inferring biological communities in aquaculture enriched sediments - Impact assessment and cost-benefit analysis
    Coutts, Alexander
    Zimmermann, Danielle
    Davey, Adam
    Bowman, John P.
    Ross, Donald J.
    Strain, Elisabeth M. A.
    MARINE POLLUTION BULLETIN, 2024, 209
  • [28] Methods for Determination of Cost-Benefit Relations for Medicines in Germany
    von der Schulenburg, J. -M. Graf
    Vauth, C.
    Mittendorf, T.
    Greiner, W.
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2007, 12 : S3 - S25
  • [29] Applied Methods of Cost-Benefit Analysis is Health Care
    Popejoy, Michael W.
    PERSPECTIVES IN PUBLIC HEALTH, 2011, 131 (01) : 48 - 48
  • [30] Applied Methods of Cost-Benefit Analysis in Health Care
    Green, C.
    JOURNAL OF PUBLIC HEALTH, 2012, 34 (02) : 317 - 317